COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 364: Articles 3631-3640  | Next

How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocol.
Vanstone, M., Correia, R., Howard, M., Darling, E., Bayrampour, H., Carruthers, A., Davis, A., Hadid, D., Hetherington, E., Jones, A., Kandasamy, S., Kuyvenhoven, C., Liauw, J., McDonald, S. D., Mniszak, C., Molinaro, M. L., Pahwa, M., Patel, T., Sadik, M., Sanya, N., Shen, K., Greyson, D.
10.1101/2023.07.10.23292463 — Posted: 2023-07-12
Investigating the 'Bolsonaro effect on the spread of the Covid-19 pandemic: an empirical analysis of observational data in Brazil
RAZAFINDRAKOTO, M., ROUBAUD, F., CASTILHO, M., PERO, V., SABOIA, J.
10.1101/2023.07.07.23292354 — Posted: 2023-07-12
Understanding Health Service Utilisation Patterns for Care Home Residents During the COVID-19 Pandemic using Routinely Collected Healthcare Data
Garner, A., Preston, N., Caiado, C., Stubington, E., Hanratty, B., Limb, J., Mason, S., Knight, J.
10.1101/2023.07.11.23292499 — Posted: 2023-07-12
The ratio between SARS-CoV-2 RNA viral load and culturable viral titer differs depending on stage of infection
Porter, M. K., Viloria Winnett, A., Hao, L., Shelby, N., Reyes, J. A., Schlenker, N. W., Romano, A. E., Tognazzini, C., Feaster, M., Goh, Y.-Y., Gale, M., Ismagilov, R. F.
10.1101/2023.07.06.23292300 — Posted: 2023-07-12
Risk-based prediction for optimal timing of booster vaccination for COVID-19 to prevent severe disease
Park, H. J., Gonsalves, G. S., Tan, S. T., Kelly, J. D., Rutherford, G. W., Wachter, R. M., Schechter, R., Paltiel, A. D., Lo, N. C.
10.1101/2023.07.10.23292473 — Posted: 2023-07-12
Impact of COVID-19 on the cascade of care for tuberculosis: A systematic review
Fapohunda, T., Mapahla, L., Taha, R., Chivese, T.
10.1101/2023.07.09.23292326 — Posted: 2023-07-12
Changes in Masking Policies in US Healthcare Facilities in the First Quarter of 2023: Do COVID-19 Cases, Hospitalizations, or Local Political Preferences Predict Loosening Restrictions?
Miller, S. L., Prasad, V.
10.1101/2023.07.11.23292518 — Posted: 2023-07-12
Risk Factors for Admission into COVID-19 General Wards, Sub-Intensive and Intensive Care Units among SARS-CoV-2 Positive Subjects in the Municipality of Bologna, Italy
Raponi, S., Durazzi, F., Derus, N. R., Giampieri, E., Miglio, R., Castellani, G., Sala, C., Bologna MODELS4COVID Study Group
10.1101/2023.07.12.23292559 — Posted: 2023-07-12
COVID-19 Case and Mortality Surveillance using Daily SARS-CoV-2 in Wastewater Samples adjusting for Meteorological Conditions and Sample pH
Samantha, A., Alsuliman, B., Penso, J., Babler, K., Sharkey, M., Mason, C., Grills, G. S., Solo-Gabriele, H., Kumar, N.
10.1101/2023.07.12.23292570 — Posted: 2023-07-12
Endocytosis Inhibitors Block SARS-CoV-2 Pseudoparticle Infection of Mink Lung Epithelium
Song, A., Phandthong, R., Talbot, P.
10.1101/2023.07.12.548725 — Posted: 2023-07-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).